慢性移植物抗宿主病治疗

Search documents
Syndax(SNDX) - 2025 Q2 - Earnings Call Transcript
2025-08-04 21:32
Syndax Pharmaceuticals (SNDX) Q2 2025 Earnings Call August 04, 2025 04:30 PM ET Company ParticipantsSharon Klahre - VP - IR & Corporate CommunicationsMichael Metzger - CEO & DirectorSteve Closter - Chief Commercial OfficerNick Botwood - Head of R&D and Chief Medical OfficerKeith Goldan - CFOAnupam Rama - Executive Director - Biotechnology Equity ResearchKevin Strang - Equity Research - BiotechnologyYigal Nochomovitz - DirectorJustin Zelin - Director - BiotechnologyDavid Dai - DirectorJason Zemansky - VP, Eq ...